FDA Drug Application (022267) for DEPAKOTE ER by ABBVIE INC

Back to FDA Applications sponsored by ABBVIE INC

Application Number022267
Product Number001
FormTABLET, EXTENDED RELEASE; ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEPAKOTE ER
Active IngredientDIVALPROEX SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIVALPROEX SODIUM4


Back to FDA Applications sponsored by ABBVIE INC